Taylor J Aiken

6PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesMedical biotechnology diagnostics (incl. biosensors)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 15, 2022
Peritoneal recurrence after resection for Stage I-III colorectal cancer: A population analysis.

Taylor Aiken, Chung-Yuan Hu, Abhineet Uppal

|May 26, 2022
Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.

Taylor J Aiken, Amy K Erbe, Lauren Zebertavage

|Sep 17, 2020
Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.

Taylor J Aiken, Christopher C Stahl, Patrick B Schwartz

|Feb 14, 2020
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses.

Jesse M Jaynes, Rushikesh Sable, Michael Ronzetti

Pageof 1